Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery

被引:4
|
作者
Basellini, Milo Jarno [1 ,2 ]
Kothuis, Josine Marie [1 ]
Comincini, Alessandro [1 ]
Pezzoli, Gianni [3 ]
Cappelletti, Graziella [1 ,4 ]
Mazzetti, Samanta [1 ,3 ]
机构
[1] Univ Milan, Dept Biosci, I-20133 Milan, Italy
[2] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona 08028, Spain
[3] Fdn Grigioni Morbo Parkinson, I-20125 Milan, Italy
[4] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2023年 / 28卷 / 02期
基金
欧盟地平线“2020”;
关键词
alpha-synuclein; microtubules; synapses; mitochondria; autophagy; inflammation; neurodegeneration; CHAPERONE-MEDIATED AUTOPHAGY; BLOOD MONONUCLEAR-CELLS; REPEAT KINASE 2; SUBSTANTIA-NIGRA; SYMPATHETIC DENERVATION; LEWY BODIES; COMPLEX-I; ORTHOSTATIC HYPOTENSION; MITOCHONDRIAL-FUNCTION; MICROTUBULE DYNAMICS;
D O I
10.31083/j.fbl2802033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alpha-synuclein inclusions are the distinctive trait of brain areas affected by neurodegeneration in Parkinson's disease (PD). Nevertheless, PD is now considered as a multisystemic disorder, since alpha-synuclein pathology has been described also outside the central nervous system. In this regard, the early, non-motor autonomic symptoms point out an important role for the peripheral nervous system during disease progression. On this basis, we propose a review of the alpha-synuclein-related pathological processes observed at peripheral level in PD, starting from molecular mechanisms, through cellular processes to systemic modifications. We discuss their relevance in the etiopathogenesis of the disease, suggesting they are concurrent players in the development of PD, and that the periphery is an easily-accessible window to look at what is occurring in the central nervous system.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Alpha-synuclein and Parkinson's disease
    Golbe, LI
    [J]. MOVEMENT DISORDERS, 1999, 14 (01) : 6 - 9
  • [2] Alpha-synuclein and Parkinson's disease
    Lücking, CB
    Brice, A
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (13-14) : 1894 - 1908
  • [3] Alpha-synuclein and Parkinson's disease
    C. B. Lücking
    A. Brice*
    [J]. Cellular and Molecular Life Sciences CMLS, 2000, 57 : 1894 - 1908
  • [4] Alpha-synuclein and protein degradation pathways in Parkinson's disease: A pathological feed-back loop
    Martinez-Vicente, Marta
    Vila, Miguel
    [J]. EXPERIMENTAL NEUROLOGY, 2013, 247 : 308 - 313
  • [5] A Noble Pathological Role for Alpha-Synuclein in Triggering Neurodegeneration of Parkinson's Disease
    Bahiraee, Alireza
    Ebrahimi, Reyhane
    [J]. MOVEMENT DISORDERS, 2018, 33 (03) : 404 - 404
  • [6] Alpha-synuclein, lipids and Parkinson's disease
    Ruiperez, Violeta
    Darios, Frederic
    Davletov, Bazbek
    [J]. PROGRESS IN LIPID RESEARCH, 2010, 49 (04) : 420 - 428
  • [7] Role of Alpha-Synuclein in Parkinson's Disease
    Link, Tina
    Maraghi, Sophie
    Reddy, Megan
    Sheth, Heli
    Stark, Kaylan
    Vijay, Varun
    [J]. FASEB JOURNAL, 2021, 35
  • [8] Alpha-synuclein spreading in Parkinson's disease
    Recasens, Ariadna
    Dehay, Benjamin
    [J]. FRONTIERS IN NEUROANATOMY, 2014, 8
  • [9] Peripheral Alpha-Synuclein and Parkinson's Disease
    Olanow, C. Warren
    Wakeman, Dustin R.
    Kordower, Jeffrey H.
    [J]. MOVEMENT DISORDERS, 2014, 29 (08) : 963 - 966
  • [10] Alpha-Synuclein as a Biomarker for Parkinson's Disease
    Atik, Anzari
    Stewart, Tessandra
    Zhang, Jing
    [J]. BRAIN PATHOLOGY, 2016, 26 (03) : 410 - 418